Evogene (EVGN) News Today $1.35 +0.06 (+4.65%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Comparing Evogene (NASDAQ:EVGN) & N2OFF (NASDAQ:NITO)December 21 at 2:13 AM | americanbankingnews.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,25 US-DollarDecember 17, 2024 | de.investing.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,44 US-DollarDecember 5, 2024 | de.investing.comEvogene price target lowered to $5 from $12 at Lake StreetNovember 22, 2024 | markets.businessinsider.comEvogene Ltd. (EVGN) Q3 2024 Earnings Call TranscriptNovember 21, 2024 | seekingalpha.comEvogene Reports Third Quarter 2024 Financial ResultsNovember 21, 2024 | prnewswire.comLake Street Keeps Their Buy Rating on Evogene (EVGN)November 20, 2024 | markets.businessinsider.comEvogene Q3 2024 Earnings PreviewNovember 20, 2024 | msn.comA Glimpse of Evogene's Earnings PotentialNovember 20, 2024 | benzinga.comLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial ResultsNovember 19, 2024 | prnewswire.comLavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field TrialsNovember 12, 2024 | prnewswire.comEvogene Schedules Third Quarter 2024 Financial Results ReleaseNovember 7, 2024 | prnewswire.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,13 US-DollarNovember 1, 2024 | de.investing.comEvogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule DesignOctober 31, 2024 | prnewswire.comCasterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in KenyaOctober 29, 2024 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Short Interest Up 83.6% in OctoberEvogene Ltd. (NASDAQ:EVGN - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 26,800 shares, an increase of 83.6% from the September 30th total of 14,600 shares. Based on an average trading volume of 32,100 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.5% of the shares of the company are short sold.October 26, 2024 | marketbeat.comEvogene (NASDAQ:EVGN) Stock Price Passes Below 200 Day Moving Average - Here's WhyEvogene (NASDAQ:EVGN) Stock Passes Below 200-Day Moving Average - What's Next?October 25, 2024 | marketbeat.comEvogene (NASDAQ:EVGN) Research Coverage Started at StockNews.comStockNews.com assumed coverage on Evogene in a research report on Friday. They set a "sell" rating on the stock.October 25, 2024 | marketbeat.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,21 US-DollarOctober 17, 2024 | de.investing.comEvogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving Average - Should You Sell?Evogene (NASDAQ:EVGN) Share Price Passes Below 200-Day Moving Average - Should You Sell?October 9, 2024 | marketbeat.comWatershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing TechnologyOctober 8, 2024 | prnewswire.comStockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)StockNews.com initiated coverage on shares of Evogene in a research report on Tuesday. They set a "sell" rating for the company.October 1, 2024 | marketbeat.comLavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-BiologicalsSeptember 30, 2024 | prnewswire.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,6 US-DollarSeptember 25, 2024 | de.investing.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,78September 16, 2024 | de.investing.comEvogene (NASDAQ:EVGN) Share Price Crosses Below 200 Day Moving Average of $6.53Evogene (NASDAQ:EVGN) Share Price Crosses Below Two Hundred Day Moving Average of $6.53September 7, 2024 | marketbeat.comEvogene secures $5.5 million in direct offeringAugust 25, 2024 | investing.comLake Street Capital Cuts Evogene (NASDAQ:EVGN) Price Target to $12.00Lake Street Capital lowered their target price on shares of Evogene from $30.00 to $12.00 and set a "buy" rating for the company in a research note on Friday.August 23, 2024 | marketbeat.comEvogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private PlacementAugust 23, 2024 | prnewswire.comEvogene: EPS übertrifft Schätzungen um 0,19 $ - Umsatz besser als erwartetAugust 23, 2024 | de.investing.comEvogene Ltd. (NASDAQ:EVGN) Q2 2024 Earnings Call TranscriptAugust 23, 2024 | msn.comEVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024August 22, 2024 | investorplace.comEvogene Reports Second Quarter 2024 Financial ResultsAugust 22, 2024 | prnewswire.comEvogene Q2 2024 Earnings PreviewAugust 21, 2024 | msn.comEvogene (EVGN) Scheduled to Post Quarterly Earnings on ThursdayEvogene (NASDAQ:EVGN) will be releasing earnings before the market opens on Thursday, August 22, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=621459)August 15, 2024 | marketbeat.comEvogene Regains Compliance with Nasdaq Minimum Closing Bid Price RuleAugust 12, 2024 | prnewswire.comEvogene Schedules Second Quarter 2024 Financial Results ReleaseAugust 12, 2024 | prnewswire.comCasterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in BrazilJuly 31, 2024 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Sees Large Decrease in Short InterestEvogene Ltd. (NASDAQ:EVGN - Get Free Report) saw a significant drop in short interest in July. As of July 15th, there was short interest totalling 3,100 shares, a drop of 95.0% from the June 30th total of 62,400 shares. Based on an average daily trading volume, of 109,100 shares, the short-interest ratio is presently 0.0 days.July 25, 2024 | marketbeat.comEvogene Ltd. (EVGN.TA)July 24, 2024 | nz.finance.yahoo.comEvogene to effect 1-for-10 reverse stock splitJuly 23, 2024 | msn.comEvogene Announces Expected Implementation of 1-for-10 Reverse Share SplitJuly 23, 2024 | prnewswire.comICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-StimulantsJuly 17, 2024 | prnewswire.comLavie Bio Announces Commercial Expansion of Yalos™ to Winter WheatJuly 2, 2024 | prnewswire.comCasterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African CountryJune 25, 2024 | prnewswire.comEVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024May 23, 2024 | investorplace.comBiomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & MelanomaMay 23, 2024 | prnewswire.comEvogene Reports First Quarter 2024 Financial ResultsMay 23, 2024 | prnewswire.comCasterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor SeedsMay 21, 2024 | prnewswire.comEvogene Schedules First Quarter 2024 Financial Results ReleaseMay 9, 2024 | prnewswire.com Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem EVGN Media Mentions By Week EVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVGN News Sentiment▼0.000.60▲Average Medical News Sentiment EVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVGN Articles This Week▼21▲EVGN Articles Average Week Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GURE News Today SNES News Today NITO News Today CNEY News Today TANH News Today LNZAW News Today PCTTU News Today LIN News Today NTR News Today AXTA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVGN Stock Alerts